Parmax Pharma informs about standalone financial results

16 Mar 2017 Evaluate

Parmax Pharma has informed about Standalone Financial Results & Limited Review for the period ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Parmax Pharma Share Price

45.28 -0.70 (-1.52%)
25-Apr-2025 12:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.35
Dr. Reddys Lab 1170.55
Cipla 1524.75
Lupin 2048.40
Zydus Lifesciences 865.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...